Panel Discussions & Other Presentations
![catch-up-on-oisaaos-year-in-review catch-up-on-oisaaos-year-in-review](https://ois.net/wp-content/uploads/2016/10/Catch-Up-on-OIS@AAO’s-Year-in-Review.jpg)
![private-funding-trends-presentation private-funding-trends-presentation](https://ois.net/wp-content/uploads/2016/11/PRIVATE-FUNDING-TRENDS-PRESENTATION-750x420.jpg)
![ois-industry-tribute-to-allergan-1 ois-industry-tribute-to-allergan-1](https://ois.net/wp-content/uploads/2016/11/OIS-INDUSTRY-TRIBUTE-TO-ALLERGAN-1-750x420.jpg)
OIS Industry Tribute to Allergan
Interviewed By:
William J. Link, PhD, Managing Director – Versant Ventures
Award Recipients:
Gavin Herbert, Founder
David Pyott, Former CEO
![building-a-global-ophthalmic-franchise building-a-global-ophthalmic-franchise](https://ois.net/wp-content/uploads/2016/11/BUILDING-A-GLOBAL-OPHTHALMIC-FRANCHISE-1-750x420.jpg)
Building a Global Ophthalmic Franchise
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
Participants:
Robert Dempsey, Franchise Head, Ophthalmics – Shire
Jerry St. Peter, VP & Head, Sun Ophthalmics – Sun Pharmaceutical Industries
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
Calvin Roberts, MD, SVP & Chief Medical Officer – Bausch + Lomb
Jim Mazzo, Global President Ophthalmic Devices – Carl Zeiss Meditec
![ophthalmic-innovation-2016-a-view-from-the-aao ophthalmic-innovation-2016-a-view-from-the-aao](https://ois.net/wp-content/uploads/2016/11/OPHTHALMIC-INNOVATION-2016-–-“A-VIEW-FROM-THE-AAO”-750x420.jpg)
Ophthalmic Innovation 2016 - A View From The AAO
David Parke, II, MD, CEO – American Academy of Ophthalmology (AAO)
![ophthalmic-innovation-2016-a-view-from-the-nei ophthalmic-innovation-2016-a-view-from-the-nei](https://ois.net/wp-content/uploads/2016/11/OPHTHALMIC-INNOVATION-2016-–-“A-VIEW-FROM-THE-NEI”-750x420.jpg)
Ophthalmic Innovation 2016 - A View From The NEI
Mala Dutta, PhD, Lead, Office of Translational Research, National Eye Institute – NIH
![introduction-of-the-ois-index introduction-of-the-ois-index](https://ois.net/wp-content/uploads/2016/11/INTRODUCTION-OF-THE-OIS-INDEX-750x420.jpg)
![innovative-financing-options-in-ophthalmology-1 innovative-financing-options-in-ophthalmology-1](https://ois.net/wp-content/uploads/2016/11/INNOVATIVE-FINANCING-OPTIONS-IN-OPHTHALMOLOGY-1-750x420.jpg)
Innovative Financing Options in Ophthalmology
Moderated By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Participants:
Sean Ianchulev, MD, MPH, Clinical Associate Professor – UCSF
Laurent Attias, Head of Strategy, BD&L and M&A – Alcon
Nir Ellenbogen, Managing Director – Eye-Lens Pte Ltd
Jeffry Weinhuff, Managing Partner – Visionary Venture Fund
Patricia Zilliox, PhD, Chief Drug Development Officer – Foundation Fighting Blindness
![masters-of-the-industry masters-of-the-industry](https://ois.net/wp-content/uploads/2016/11/MASTERS-OF-THE-INDUSTRY-750x420.jpg)
Masters of The Industry
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices – Carl Zeiss Meditec
Participants:
Flemming Ornskov, MD, CEO – Shire
Mike Ball, CEO – Alcon
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director – Versant Ventures
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec
William Meury, Chief Commercial Officer – Allergan